In this Issue:
The burden of IPF
Nintedanib in IPF: The INPULSIS™ trials
Serum LOXL2 linked to IPF disease progression
Biomarker prediction of acute exacerbation of IPF
Early dexmedetomidine during NIV for ARF
Passive smoking and risk of COPD
Clinical characteristics of hyperinflation in COPD
Upfront triple therapy for severe PAH?
Weight loss in severe asthma with obesity
OSA after withdrawal of CPAP
Please login below to download this issue (PDF)